PEG conjugated VEGF siRNA for anti-angiogenic gene therapy
- 1 November 2006
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 116 (2) , 123-129
- https://doi.org/10.1016/j.jconrel.2006.05.023
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- RNA interference in cancerBiomolecular Engineering, 2006
- The genesis of RNA interference, its potential clinical applications, and implications in gynecologic cancerGynecologic Oncology, 2005
- RNA interference – a new experimental and therapeutic toolCurrent Opinion in Nephrology and Hypertension, 2005
- Aquaporins of the PIP2 Class Are Required for Efficient Anther Dehiscence in TobaccoPlant Physiology, 2005
- A rapid and sensitive assay for quantification of siRNA efficiency and specificityBiological Procedures Online, 2005
- Rational siRNA design for RNA interferenceNature Biotechnology, 2004
- A new synthesis of galactose-poly(ethylene glycol)-polyethylenimine for gene delivery to hepatocytes.Journal of Controlled Release, 2002
- Role for a bidentate ribonuclease in the initiation step of RNA interferenceNature, 2001
- RNAiCell, 2000
- RNA–DNA Interactions and DNA Methylation in Post-Transcriptional Gene SilencingPlant Cell, 1999